Submit Manuscript    >>    Login | Register

Subxiphoid Hybrid Approach for Epicardial/Endocardial Ablation and LAA Exclusion in Patients with Persistent and Longstanding Atrial Fibrillation


Two patients with long-standing atrial fibrillation (AF) refractory to medical management and with prior pulmonary vein isolation underwent a new hybrid epicardial/endocardial subxyphoid approach for AF ablation and left atrial appendage (LAA) ligation. Pulmonary vein and LA posterior wall isolation, as well as LAA exclusion were achieved in both patients. There were no procedural complications. Both patients remain in sinus rhythm. Both patients are off antiarrhythmic medications.

Credits: Nitish Badhwar, MD, Ghannam Al-Dosari, MD, Jonathan Dukes, MD, Randall J. Lee, MD, PhD



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists